Debt financing for
Healthcare & MedTech
Healthcare companies combine defensive, non-cyclical demand with revenue that is often backed by reimbursement or long-term contracts, characteristics debt investors value highly. Equipment and receivables add hard collateral that can lower the cost of capital further.
Lenders focus on the durability of the revenue path: regulatory status, who actually pays, and how exposed pricing is to policy change. Post-approval, post-revenue businesses have the widest set of options.
Best-fit products
The structures that work in Healthcare & MedTech
Cashflow financing
Venture Debt
Non-dilutive runway for VC-backed companies, alongside or after a round.
$2M-$30MCashflow financing
Growth Debt
Larger, cheaper debt for scale-ups with established revenues.
$10M-$100MAsset-backed financing
Asset-Backed Lending
Revolving lines against receivables, inventory, MRR, or equipment.
$5M-$200MWhat lenders like
Why the sector attracts debt capital
- Defensive, non-cyclical demand holds up through downturns
- Reimbursement and long-term contracts give revenue durability
- Equipment and receivables provide hard collateral
- Regulatory approval, once secured, is itself a moat lenders value
What investors will ask
The diligence questions to be ready for
- Regulatory status: CE marking / FDA clearance, and what is still pending
- Reimbursement risk: who pays, under what codes, and how exposed is pricing to policy change?
- Payer or provider concentration across the revenue base
- Length of sales cycles and the working capital they consume
Products, criteria, and themes shown are indicative, not exhaustive, and subject to further diligence on the company and its assets. Every business is assessed on its own merits.
Track record
Deals we've advised in the sector
€3.5M
Venture Debt
Healthcare
€22M
Growth Debt
MedTech
€12M
Venture Debt
Healthtech
Healthcare & MedTech FAQ
What founders and CFOs in the sector ask us most.
Still have questions? Talk to usYes, typically once regulatory approval is secured and commercial revenue has started. Venture debt and growth debt are the usual routes, with sizing driven by revenue quality and the strength of equity backing, subject to diligence.
Other sectors we cover
SaaS & B2B Software
Debt sized on ARR and gross profit, not EBITDA.
Learn moreFintech & Specialty Lenders
Warehouse and back-leverage facilities that scale with your loan book.
Learn moreE-commerce & Consumer Brands
Fund inventory and growth with the stock itself as collateral.
Learn moreMarketplaces & Platforms
Asset-light models financed on take-rate revenue and payment flows.
Learn moreHardware, Robotics & DeepTech
Tangible assets and order books that de-risk the lend.
Learn moreRaising in Healthcare & MedTech?
Tell us about the business and we'll come back with an indicative view of structure, investors, and terms. No cost, no obligation.